{"entity":{"type":"insider","cik":"0001564926","url":"/insider/0001564926","json_url":"/insider/0001564926.json","name":"O'NEIL PATRICK R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":169,"n_filings":82,"first":"2013-01-04","last":"2026-06-30","span_basis":"filed_date"},"name_variants":[{"name":"O'NEIL PATRICK R.","source":"filing","n_filings":82,"first_seen":"2013-01-04","last_seen":"2026-06-30"}],"transactions":[{"id":6163757,"accession":"0000874015-26-000217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-26-000217","line_url":"/filing/0000874015-26-000217#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3069.0,"shares_display":"3,069","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":245520.0,"total_display":"245,520.00","total_whole":"245,520","shares_owned_after":61470.0,"shares_owned_after_display":"61,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5891543,"accession":"0000874015-26-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-26-000144","line_url":"/filing/0000874015-26-000144#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10148.0,"shares_display":"10,148","price_per_share":75.2525,"price_display":"75.25","price_state":"stated","total_value":763662.37,"total_display":"763,662.37","total_whole":"763,662","shares_owned_after":62211.0,"shares_owned_after_display":"62,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":5760984,"accession":"0000874015-26-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000100","line_url":"/filing/0000874015-26-000100#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6179.0,"shares_display":"6,179","price_per_share":83.5335,"price_display":"83.53","price_state":"stated","total_value":516153.4965,"total_display":"516,153.50","total_whole":"516,153","shares_owned_after":71983.0,"shares_owned_after_display":"71,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":5780716,"accession":"0000874015-26-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000070","line_url":"/filing/0000874015-26-000070#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9191.0,"shares_display":"9,191","price_per_share":75.84,"price_display":"75.84","price_state":"stated","total_value":697045.44,"total_display":"697,045.44","total_whole":"697,045","shares_owned_after":66171.0,"shares_owned_after_display":"66,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":4161525,"accession":"0000874015-25-000253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000874015-25-000253","line_url":"/filing/0000874015-25-000253","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13441.0,"shares_display":"13,441","price_per_share":69.73719433821888,"price_display":"69.74","price_state":"stated","total_value":937337.6291,"total_display":"937,337.63","total_whole":"937,338","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider","n_lines":2},{"id":4869966,"accession":"0000874015-25-000244","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-25-000244","line_url":"/filing/0000874015-25-000244","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64664.0,"shares_display":"64,664","price_per_share":67.6892,"price_display":"67.69","price_state":"stated","total_value":4377054.4288,"total_display":"4,377,054.43","total_whole":"4,377,054","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-02","scope":"insider","n_lines":2},{"id":4057889,"accession":"0000874015-25-000240","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-25-000240","line_url":"/filing/0000874015-25-000240#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14827.0,"shares_display":"14,827","price_per_share":64.6777,"price_display":"64.68","price_state":"stated","total_value":958976.2579,"total_display":"958,976.26","total_whole":"958,976","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4057887,"accession":"0000874015-25-000240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000240","line_url":"/filing/0000874015-25-000240#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10473.0,"shares_display":"10,473","price_per_share":64.5417,"price_display":"64.54","price_state":"stated","total_value":675945.2241,"total_display":"675,945.22","total_whole":"675,945","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":5103861,"accession":"0000874015-25-000234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000234","line_url":"/filing/0000874015-25-000234#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":64.5807,"price_display":"64.58","price_state":"stated","total_value":109787.19,"total_display":"109,787.19","total_whole":"109,787","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-16","scope":"insider"},{"id":4572903,"accession":"0000874015-25-000231","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-25-000231","line_url":"/filing/0000874015-25-000231","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":64.5553,"price_display":"64.56","price_state":"stated","total_value":1355661.3,"total_display":"1,355,661.30","total_whole":"1,355,661","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-11","scope":"insider","n_lines":2},{"id":4903436,"accession":"0000874015-25-000214","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000874015-25-000214","line_url":"/filing/0000874015-25-000214","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76850.0,"shares_display":"76,850","price_per_share":60.968448275862066,"price_display":"60.97","price_state":"stated","total_value":4685425.25,"total_display":"4,685,425.25","total_whole":"4,685,425","shares_owned_after":5655.0,"shares_owned_after_display":"5,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-04","scope":"insider","n_lines":2},{"id":4903415,"accession":"0000874015-25-000214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000214","line_url":"/filing/0000874015-25-000214#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13050.0,"shares_display":"13,050","price_per_share":54.5148,"price_display":"54.51","price_state":"stated","total_value":711418.14,"total_display":"711,418.14","total_whole":"711,418","shares_owned_after":57130.0,"shares_owned_after_display":"57,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":5148195,"accession":"0000874015-25-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000091","line_url":"/filing/0000874015-25-000091#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":32.35,"price_display":"32.35","price_state":"stated","total_value":39046.45,"total_display":"39,046.45","total_whole":"39,046","shares_owned_after":56245.0,"shares_owned_after_display":"56,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-24","scope":"insider"},{"id":4191739,"accession":"0000874015-25-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000085","line_url":"/filing/0000874015-25-000085#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6165.0,"shares_display":"6,165","price_per_share":31.6203,"price_display":"31.62","price_state":"stated","total_value":194939.1495,"total_display":"194,939.15","total_whole":"194,939","shares_owned_after":57452.0,"shares_owned_after_display":"57,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":4042889,"accession":"0000874015-25-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000079","line_url":"/filing/0000874015-25-000079#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1406.0,"shares_display":"1,406","price_per_share":32.4926,"price_display":"32.49","price_state":"stated","total_value":45684.5956,"total_display":"45,684.60","total_whole":"45,685","shares_owned_after":63617.0,"shares_owned_after_display":"63,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider"},{"id":4225535,"accession":"0000874015-25-000063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000063","line_url":"/filing/0000874015-25-000063#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7360.0,"shares_display":"7,360","price_per_share":32.83,"price_display":"32.83","price_state":"stated","total_value":241628.8,"total_display":"241,628.80","total_whole":"241,629","shares_owned_after":61203.0,"shares_owned_after_display":"61,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":9201497,"accession":"0000874015-24-000198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000198","line_url":"/filing/0000874015-24-000198#line-1","is_derivative":false,"issuer_cik":"0001564926","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0001564926","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1995.0,"shares_display":"1,995","price_per_share":49.6738,"price_display":"49.67","price_state":"stated","total_value":99099.231,"total_display":"99,099.23","total_whole":"99,099","shares_owned_after":48627.0,"shares_owned_after_display":"48,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-09-04","scope":"insider"},{"id":2620721,"accession":"0000874015-24-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000108","line_url":"/filing/0000874015-24-000108#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1961.0,"shares_display":"1,961","price_per_share":49.6738,"price_display":"49.67","price_state":"stated","total_value":97410.3218,"total_display":"97,410.32","total_whole":"97,410","shares_owned_after":48661.0,"shares_owned_after_display":"48,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-02","scope":"insider"},{"id":2267339,"accession":"0000874015-24-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000084","line_url":"/filing/0000874015-24-000084#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6450.0,"shares_display":"6,450","price_per_share":51.75,"price_display":"51.75","price_state":"stated","total_value":333787.5,"total_display":"333,787.50","total_whole":"333,788","shares_owned_after":46802.0,"shares_owned_after_display":"46,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2763526,"accession":"0000874015-24-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000080","line_url":"/filing/0000874015-24-000080#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7744.0,"shares_display":"7,744","price_per_share":50.417,"price_display":"50.42","price_state":"stated","total_value":390429.248,"total_display":"390,429.25","total_whole":"390,429","shares_owned_after":53252.0,"shares_owned_after_display":"53,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-18","scope":"insider"},{"id":8568239,"accession":"0000874015-23-000242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000242","line_url":"/filing/0000874015-23-000242#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20825.0,"shares_display":"20,825","price_per_share":51.463,"price_display":"51.46","price_state":"stated","total_value":1071716.975,"total_display":"1,071,716.98","total_whole":"1,071,717","shares_owned_after":40355.0,"shares_owned_after_display":"40,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8184460,"accession":"0000874015-23-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-23-000140","line_url":"/filing/0000874015-23-000140#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1527.0,"shares_display":"1,527","price_per_share":41.7,"price_display":"41.70","price_state":"stated","total_value":63675.9,"total_display":"63,675.90","total_whole":"63,676","shares_owned_after":40355.0,"shares_owned_after_display":"40,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-24","scope":"insider"},{"id":8619645,"accession":"0000874015-23-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000094","line_url":"/filing/0000874015-23-000094#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1920.0,"shares_display":"1,920","price_per_share":40.8648,"price_display":"40.86","price_state":"stated","total_value":78460.416,"total_display":"78,460.42","total_whole":"78,460","shares_owned_after":41581.0,"shares_owned_after_display":"41,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider"},{"id":8668639,"accession":"0000874015-23-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000072","line_url":"/filing/0000874015-23-000072#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":39.7111,"price_display":"39.71","price_state":"stated","total_value":178699.95,"total_display":"178,699.95","total_whole":"178,700","shares_owned_after":39679.0,"shares_owned_after_display":"39,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":8668635,"accession":"0000874015-23-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-23-000072","line_url":"/filing/0000874015-23-000072#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":39.416,"price_display":"39.42","price_state":"stated","total_value":177372.0,"total_display":"177,372.00","total_whole":"177,372","shares_owned_after":44179.0,"shares_owned_after_display":"44,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-02","scope":"insider"},{"id":8243644,"accession":"0000874015-23-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000067","line_url":"/filing/0000874015-23-000067#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7836.0,"shares_display":"7,836","price_per_share":39.4946,"price_display":"39.49","price_state":"stated","total_value":309479.6856,"total_display":"309,479.69","total_whole":"309,480","shares_owned_after":48679.0,"shares_owned_after_display":"48,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":6116395,"accession":"0000874015-22-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-22-000095","line_url":"/filing/0000874015-22-000095#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP CLO & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP CLO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CLO & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6792.0,"shares_display":"6,792","price_per_share":40.0555,"price_display":"40.06","price_state":"stated","total_value":272056.956,"total_display":"272,056.96","total_whole":"272,057","shares_owned_after":34536.0,"shares_owned_after_display":"34,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":5426744,"accession":"0000874015-21-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-21-000049","line_url":"/filing/0000874015-21-000049#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5324.0,"shares_display":"5,324","price_per_share":63.5,"price_display":"63.50","price_state":"stated","total_value":338074.0,"total_display":"338,074.00","total_whole":"338,074","shares_owned_after":26502.0,"shares_owned_after_display":"26,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":2539777,"accession":"0000874015-20-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-20-000045","line_url":"/filing/0000874015-20-000045#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3882.0,"shares_display":"3,882","price_per_share":59.6,"price_display":"59.60","price_state":"stated","total_value":231367.2,"total_display":"231,367.20","total_whole":"231,367","shares_owned_after":20720.0,"shares_owned_after_display":"20,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":8021608,"accession":"0000874015-19-000057","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000874015-19-000057","line_url":"/filing/0000874015-19-000057#line-18","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2252.0,"shares_display":"2,252","price_per_share":84.75,"price_display":"84.75","price_state":"stated","total_value":190857.0,"total_display":"190,857.00","total_whole":"190,857","shares_owned_after":16673.0,"shares_owned_after_display":"16,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-05","scope":"insider"},{"id":8021604,"accession":"0000874015-19-000057","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000874015-19-000057","line_url":"/filing/0000874015-19-000057","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39622.0,"shares_display":"39,622","price_per_share":83.79004845792741,"price_display":"83.79","price_state":"stated","total_value":3319929.3,"total_display":"3,319,929.30","total_whole":"3,319,929","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-04","filed_date":"2019-04-05","scope":"insider","n_lines":8},{"id":8021579,"accession":"0000874015-19-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000057","line_url":"/filing/0000874015-19-000057#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7654.0,"shares_display":"7,654","price_per_share":84.83,"price_display":"84.83","price_state":"stated","total_value":649288.82,"total_display":"649,288.82","total_whole":"649,289","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-03","filed_date":"2019-04-05","scope":"insider"},{"id":8339025,"accession":"0000874015-19-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000055","line_url":"/filing/0000874015-19-000055#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28800.0,"shares_display":"28,800","price_per_share":78.7912,"price_display":"78.79","price_state":"stated","total_value":2269186.56,"total_display":"2,269,186.56","total_whole":"2,269,187","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-20","scope":"insider"},{"id":8436061,"accession":"0000874015-19-000047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000874015-19-000047","line_url":"/filing/0000874015-19-000047","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26800.0,"shares_display":"26,800","price_per_share":68.00669850746269,"price_display":"68.01","price_state":"stated","total_value":1822579.52,"total_display":"1,822,579.52","total_whole":"1,822,580","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-27","filed_date":"2019-03-01","scope":"insider","n_lines":3},{"id":7804050,"accession":"0000874015-19-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000040","line_url":"/filing/0000874015-19-000040#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275.0,"shares_display":"275","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":16362.5,"total_display":"16,362.50","total_whole":"16,363","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"},{"id":7774935,"accession":"0000874015-19-000034","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-19-000034","line_url":"/filing/0000874015-19-000034#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15600.0,"shares_display":"15,600","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":928200.0,"total_display":"928,200.00","total_whole":"928,200","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-05","scope":"insider"},{"id":7774928,"accession":"0000874015-19-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000034","line_url":"/filing/0000874015-19-000034#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001564926","owner_name":"O'NEIL PATRICK R.","owner_display_name":"O'NEIL PATRICK R.","owner_url":"/insider/0001564926","role":"Officer (SVP Legal & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP Legal & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Legal & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":58.29,"price_display":"58.29","price_state":"stated","total_value":233160.0,"total_display":"233,160.00","total_whole":"233,160","shares_owned_after":19673.0,"shares_owned_after_display":"19,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-05","scope":"insider"}],"collapsed":true,"next_cursor":"2019-02-01|7774928","ledger_fault":false,"count":{"value":169,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":169,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":169},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Officer (EVP CLO & General Counsel)","n_filings":82,"first_seen":"2013-01-04","last_seen":"2026-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001564926","retrieved_at":"2026-08-23T12:15:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}